EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Numinus Wellness's enterprise value is $10.71 Mil.
Numinus Wellness's EBITDA for the trailing twelve months (TTM) ended in May. 2025 was $-8.94 Mil. Therefore, Numinus Wellness's EV-to-EBITDA for today is -1.20.
The historical rank and industry rank for Numinus Wellness's EV-to-EBITDA or its related term are showing as below:
NUMIF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.55 Med: 0 Max: 0
Current: -1.2
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Numinus Wellness's PE Ratio (TTM) for today is calculated as:
Numinus Wellness's share price for today is $0.0301.
Numinus Wellness's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.028.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Numinus Wellness's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NUMIF vs HLYK, SYRA, GBCS: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Numinus Wellness's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Numinus Wellness EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Numinus Wellness's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Numinus Wellness's EV-to-EBITDA falls into.
Numinus Wellness's current Enterprise Value is $10.71 Mil.
Numinus Wellness's EBITDA for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.94 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Numinus Wellness (NUMIF) has a EV-to-EBITDA of -1.20 as of Jul. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Numinus Wellness.
Is Numinus Wellness' EV-to-EBITDA too high?
Numinus Wellness' current EV-to-EBITDA is -1.20.
How does Numinus Wellness' EV-to-EBITDA compare to HLYK and SYRA?
Numinus Wellness' EV-to-EBITDA of -1.20 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBITDA is 10.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.84, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Numinus Wellness. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Numinus Wellness's current EV-to-EBITDA is -1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current EV-to-EBITDA of -1.20. The current EV-to-EBITDA is -1.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current EV-to-EBITDA is -1.20 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUMIF has been successfully added to your 